Veeva Systems Case Studies Pfizer: Streamlining Content Supply Chain with IoT

Edit This Case Study Record

	Pfizer: Streamlining Content Supply Chain with IoT Veeva Systems

Pfizer: Streamlining Content Supply Chain with IoT

Veeva Systems

Technology Category	Sensors - Optical Sensors
Applicable Industries	Healthcare & Hospitals
Applicable Functions	Logistics & Transportation Sales & Marketing
Use Cases	Leasing Finance Automation Material Handling Automation
Challenge	Pfizer, a leading biopharma enterprise, was facing challenges in managing its content supply chain. The company was grappling with the need to provide more fluid and personalized content to its customers. The operations team was tasked with overseeing the creation, approval, and dissemination of marketing and medical content. They also had to manage the data ecosystem, which included capturing and managing information and stewarding healthcare professional interaction data. The shift from multichannel to omnichannel communication was a key priority, but it presented significant challenges. Integrating channels that had been operating independently was a daunting task, and the company had to either spend time stitching them together or start afresh. Additionally, the company had to bring new capabilities, like metadata, to the fore to inform data-driven decisions. Read More
About Customer	Pfizer is a leading global biopharma company headquartered in New York, United States. The company is committed to discovering, developing, and delivering innovative therapies that improve patients' lives. Pfizer's operations team oversees services that enable marketing and medical content creation, approval, and dissemination. They also manage the data ecosystem, which includes everything associated with managing and capturing information and helping steward healthcare professional interaction data. The company is focused on elevating its game by providing more fluid and personalized content to its customers and shifting from multichannel to omnichannel communication. Read More
Solution	Pfizer adopted a strategic approach to address these challenges. The first step was to lay out the current processes, tools, and technologies for content creation and interaction with physicians or patients. The company then identified the critical areas causing the most inefficiencies and prioritized efforts to address these gaps. For instance, Pfizer identified metadata as a significant gap and took steps to close it. The company also streamlined its review and approval processes, creating a tiered review process based on the magnitude of changes. Pfizer also reinforced global to local content creation, encouraging the use of globally created content at the local level. While the goal of 100% automation was deemed a stretch in the short term, Pfizer focused on enabling review time for the parts that mattered by applying tiering, grouping, or modularizing commensurate with the risk. Read More Log in to view content
Contents

Technology Category

Sensors - Optical Sensors

Applicable Industries

Healthcare & Hospitals

Applicable Functions

Logistics & Transportation

Sales & Marketing

Use Cases

Leasing Finance Automation

Material Handling Automation

Challenge

Pfizer, a leading biopharma enterprise, was facing challenges in managing its content supply chain. The company was grappling with the need to provide more fluid and personalized content to its customers. The operations team was tasked with overseeing the creation, approval, and dissemination of marketing and medical content. They also had to manage the data ecosystem, which included capturing and managing information and stewarding healthcare professional interaction data. The shift from multichannel to omnichannel communication was a key priority, but it presented significant challenges. Integrating channels that had been operating independently was a daunting task, and the company had to either spend time stitching them together or start afresh. Additionally, the company had to bring new capabilities, like metadata, to the fore to inform data-driven decisions.

About Customer

Pfizer is a leading global biopharma company headquartered in New York, United States. The company is committed to discovering, developing, and delivering innovative therapies that improve patients' lives. Pfizer's operations team oversees services that enable marketing and medical content creation, approval, and dissemination. They also manage the data ecosystem, which includes everything associated with managing and capturing information and helping steward healthcare professional interaction data. The company is focused on elevating its game by providing more fluid and personalized content to its customers and shifting from multichannel to omnichannel communication.

Solution

Pfizer adopted a strategic approach to address these challenges. The first step was to lay out the current processes, tools, and technologies for content creation and interaction with physicians or patients. The company then identified the critical areas causing the most inefficiencies and prioritized efforts to address these gaps. For instance, Pfizer identified metadata as a significant gap and took steps to close it. The company also streamlined its review and approval processes, creating a tiered review process based on the magnitude of changes. Pfizer also reinforced global to local content creation, encouraging the use of globally created content at the local level. While the goal of 100% automation was deemed a stretch in the short term, Pfizer focused on enabling review time for the parts that mattered by applying tiering, grouping, or modularizing commensurate with the risk.

Impact #1	Pfizer's strategic approach to managing its content supply chain has resulted in several operational benefits. The company has been able to streamline its content creation and dissemination processes, leading to more efficient operations. The shift from multichannel to omnichannel communication has enabled more personalized interactions with customers. The introduction of a tiered review process has simplified and streamlined the review and approval processes, reducing the time and effort required. The focus on using globally created content at the local level has eliminated the need for creating new, bespoke content for each region, leading to significant time and cost savings. While the goal of 100% automation is still a stretch, the company has made significant strides in this direction by enabling review time for the parts that matter.

Impact #1

Pfizer's strategic approach to managing its content supply chain has resulted in several operational benefits. The company has been able to streamline its content creation and dissemination processes, leading to more efficient operations. The shift from multichannel to omnichannel communication has enabled more personalized interactions with customers. The introduction of a tiered review process has simplified and streamlined the review and approval processes, reducing the time and effort required. The focus on using globally created content at the local level has eliminated the need for creating new, bespoke content for each region, leading to significant time and cost savings. While the goal of 100% automation is still a stretch, the company has made significant strides in this direction by enabling review time for the parts that matter.

Download PDF Version

Overview

Pfizer: Streamlining Content Supply Chain with IoT

Operational Impact